• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植耐受,非仅克隆删除。

Transplant Tolerance, Not Only Clonal Deletion.

机构信息

Immune Tolerance Laboratory, School of Medicine, University of New South Wales (UNSW) Sydney, Ingham Institute, and Renal Service and Multiple Sclerosis Clinic, Liverpool Hospital, Liverpool, NSW, Australia.

出版信息

Front Immunol. 2022 Apr 21;13:810798. doi: 10.3389/fimmu.2022.810798. eCollection 2022.

DOI:10.3389/fimmu.2022.810798
PMID:35529847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9069565/
Abstract

The quest to understand how allogeneic transplanted tissue is not rejected and how tolerance is induced led to fundamental concepts in immunology. First, we review the research that led to the Clonal Deletion theory in the late 1950s that has since dominated the field of immunology and transplantation. At that time many basic mechanisms of immune response were unknown, including the role of lymphocytes and T cells in rejection. These original observations are reassessed by considering T regulatory cells that are produced by thymus of neonates to prevent autoimmunity. Second, we review "operational tolerance" induced in adult rodents and larger animals such as pigs. This can occur spontaneously especially with liver allografts, but also can develop after short courses of a variety of rejection inhibiting therapies. Over time these animals develop alloantigen specific tolerance to the graft but retain the capacity to reject third-party grafts. These animals have a "split tolerance" as peripheral lymphocytes from these animals respond to donor alloantigen in graft versus host assays and in mixed lymphocyte cultures, indicating there is no clonal deletion. Investigation of this phenomenon excludes many mechanisms, including anti-donor antibody blocking rejection as well as anti-idiotypic responses mediated by antibody or T cells. This split tolerance is transferred to a second immune-depleted host by T cells that retain the capacity to effect rejection of third-party grafts by the same host. Third, we review research on alloantigen specific inhibitory T cells that led to the first identification of the CD4CD25T regulatory cell. The key role of T cell derived cytokines, other than IL-2, in promoting survival and expansion of antigen specific T regulatory cells that mediate transplant tolerance is reviewed. The precise methods for inducing and diagnosing operational tolerance remain to be defined, but antigen specific T regulatory cells are key mediators.

摘要

探索异体移植组织不被排斥以及诱导耐受的机制导致了免疫学的基本概念的产生。首先,我们回顾了 20 世纪 50 年代后期导致克隆删除理论的研究,该理论从此主导了免疫学和移植学领域。当时,许多免疫反应的基本机制尚不清楚,包括淋巴细胞和 T 细胞在排斥反应中的作用。通过考虑新生儿胸腺产生的 T 调节细胞来预防自身免疫,重新评估这些最初的观察结果。其次,我们回顾了成年啮齿动物和较大动物(如猪)中诱导的“操作性耐受”。这种情况尤其会在肝脏移植物中自发发生,但也可以在接受各种抑制排斥的治疗后短期发生。随着时间的推移,这些动物会对移植物产生同种异体抗原特异性耐受,但仍保留排斥第三方移植物的能力。这些动物具有“分裂耐受”,因为来自这些动物的外周淋巴细胞在移植物抗宿主测定和混合淋巴细胞培养中对供体同种异体抗原作出反应,表明不存在克隆删除。对这一现象的研究排除了许多机制,包括抗供体抗体阻断排斥反应以及抗体或 T 细胞介导的抗独特型反应。通过同种异体抗原特异性抑制性 T 细胞的研究,我们转移了这种分裂耐受到第二个免疫耗竭的宿主,这些 T 细胞保留了通过同一宿主排斥第三方移植物的能力。第三,我们回顾了关于同种异体抗原特异性抑制性 T 细胞的研究,这些研究导致了第一个 CD4CD25T 调节性 T 细胞的鉴定。审查了 T 细胞衍生细胞因子(除了 IL-2 以外)在促进同种抗原特异性 T 调节细胞存活和扩增中的关键作用,这些细胞调节移植耐受。诱导和诊断操作性耐受的确切方法仍有待确定,但抗原特异性 T 调节细胞是关键介质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1143/9069565/99be10b8382b/fimmu-13-810798-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1143/9069565/96b4de1febd6/fimmu-13-810798-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1143/9069565/0a264023d6c7/fimmu-13-810798-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1143/9069565/99be10b8382b/fimmu-13-810798-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1143/9069565/96b4de1febd6/fimmu-13-810798-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1143/9069565/0a264023d6c7/fimmu-13-810798-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1143/9069565/99be10b8382b/fimmu-13-810798-g003.jpg

相似文献

1
Transplant Tolerance, Not Only Clonal Deletion.移植耐受,非仅克隆删除。
Front Immunol. 2022 Apr 21;13:810798. doi: 10.3389/fimmu.2022.810798. eCollection 2022.
2
Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.影响移植耐受中 CD4(+)T 调节细胞的细胞因子。白细胞介素-4 不能维持同种抗原特异性 CD4(+)CD25(+)Treg。
Transpl Immunol. 2013 Dec;29(1-4):51-9. doi: 10.1016/j.trim.2013.10.003. Epub 2013 Oct 16.
3
Cytokines affecting CD4T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4 T regulatory cells.影响移植耐受中CD4 T调节性细胞的细胞因子。III. 白细胞介素-5(IL-5)促进同种异体抗原特异性CD4 T调节性细胞的存活。
Transpl Immunol. 2017 Aug;43-44:33-41. doi: 10.1016/j.trim.2017.06.003. Epub 2017 Jun 23.
4
Alloantigen specific T regulatory cells in transplant tolerance.同种异体抗原特异性 T 调节细胞在移植耐受中的作用。
Int Immunopharmacol. 2009 May;9(5):570-4. doi: 10.1016/j.intimp.2009.01.016. Epub 2009 Jan 29.
5
Cytokines affecting CD4T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4T regulatory cells.影响移植耐受中CD4T调节性细胞的细胞因子。II. 干扰素γ(IFN-γ)促进同种抗原特异性CD4T调节性细胞的存活。
Transpl Immunol. 2017 Jun;42:24-33. doi: 10.1016/j.trim.2017.05.002. Epub 2017 May 6.
6
Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.体外供体同种异体抗原刺激的CD4(+)CD25(+)调节性T细胞的过继性输血可改善DA到Lewis大鼠肝移植的排斥反应。
Surgery. 2007 Jul;142(1):67-73. doi: 10.1016/j.surg.2007.02.014.
7
CD4+CD25+ T Regulatory Cells in Transplantation Tolerance: 25 Years On.移植耐受中的CD4+CD25+调节性T细胞:25年回顾
Transplantation. 2016 Dec;100(12):2533-2547. doi: 10.1097/TP.0000000000001436.
8
Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4CD25 Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.白细胞介素-5(IL-5)治疗通过促进抗原特异性表达白细胞介素-5 受体的 CD4CD25Ts2 调节性 T 细胞来预防同种异体移植排斥。
Front Immunol. 2021 Nov 29;12:714838. doi: 10.3389/fimmu.2021.714838. eCollection 2021.
9
Ablation of interferon regulatory factor 4 in T cells induces "memory" of transplant tolerance that is irreversible by immune checkpoint blockade.T 细胞中干扰素调节因子 4 的消融诱导移植耐受的“记忆”,这种“记忆”不能被免疫检查点阻断所逆转。
Am J Transplant. 2019 Mar;19(3):884-893. doi: 10.1111/ajt.15196. Epub 2018 Dec 25.
10
Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function.双阴性调节性 T 细胞通过诱导 T 细胞克隆性删除和抑制 NK 细胞功能来促进非清髓性骨髓嵌合。
Eur J Immunol. 2012 May;42(5):1216-25. doi: 10.1002/eji.201141808.

引用本文的文献

1
Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?抗肌萎缩蛋白的免疫原性是否会阻碍杜氏肌营养不良症基因治疗的进展?
Gene Ther. 2025 Apr 3. doi: 10.1038/s41434-025-00531-y.
2
CD4CD25 T regulatory cells in renal transplantation.肾移植中的 CD4CD25T 调节性细胞。
Front Immunol. 2022 Nov 8;13:1017683. doi: 10.3389/fimmu.2022.1017683. eCollection 2022.

本文引用的文献

1
Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4CD25 Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.白细胞介素-5(IL-5)治疗通过促进抗原特异性表达白细胞介素-5 受体的 CD4CD25Ts2 调节性 T 细胞来预防同种异体移植排斥。
Front Immunol. 2021 Nov 29;12:714838. doi: 10.3389/fimmu.2021.714838. eCollection 2021.
2
Early Thymectomy Is Associated With Long-Term Impairment of the Immune System: A Systematic Review.早期胸腺切除术与免疫系统长期受损相关:系统评价。
Front Immunol. 2021 Nov 25;12:774780. doi: 10.3389/fimmu.2021.774780. eCollection 2021.
3
Multiple sclerosis patients have reduced resting and increased activated CD4CD25FOXP3T regulatory cells.
多发性硬化症患者的静止 CD4CD25FOXP3T 调节性细胞减少,激活的 CD4CD25FOXP3T 调节性细胞增加。
Sci Rep. 2021 May 18;11(1):10476. doi: 10.1038/s41598-021-88448-5.
4
Induction Phase of Spontaneous Liver Transplant Tolerance.自发性肝移植耐受的诱导阶段。
Front Immunol. 2020 Sep 11;11:1908. doi: 10.3389/fimmu.2020.01908. eCollection 2020.
5
The Fourth International Workshop on Clinical Transplant Tolerance.第四届临床移植耐受国际研讨会。
Am J Transplant. 2021 Jan;21(1):21-31. doi: 10.1111/ajt.16139. Epub 2020 Jul 22.
6
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.肾移植中的调节性细胞治疗(ONE 研究):七个非随机、单臂、1/2A 期的临床试验的协调设计和分析。
Lancet. 2020 May 23;395(10237):1627-1639. doi: 10.1016/S0140-6736(20)30167-7.
7
Autoantigen specific IL-2 activated CD4CD25T regulatory cells inhibit induction of experimental autoimmune neuritis.自身抗原特异性 IL-2 激活的 CD4+CD25+T 调节细胞抑制实验性自身免疫性神经炎的诱导。
J Neuroimmunol. 2020 Apr 15;341:577186. doi: 10.1016/j.jneuroim.2020.577186. Epub 2020 Feb 3.
8
Alloactivation of Naïve CD4CD8CD25T Regulatory Cells: Expression of CD8α Identifies Potent Suppressor Cells That Can Promote Transplant Tolerance Induction.幼稚 CD4CD8CD25T 调节性细胞的 alloactivation:CD8α 的表达鉴定了能够促进移植耐受诱导的有效抑制细胞。
Front Immunol. 2019 Oct 14;10:2397. doi: 10.3389/fimmu.2019.02397. eCollection 2019.
9
Twenty Years of AIRE.二十载 AIRE 历程。
Front Immunol. 2018 Feb 12;9:98. doi: 10.3389/fimmu.2018.00098. eCollection 2018.
10
Anti-donor regulatory T cell therapy in liver transplantation.肝移植中的抗供体调节性T细胞疗法
Hum Immunol. 2018 May;79(5):288-293. doi: 10.1016/j.humimm.2017.12.010. Epub 2017 Dec 29.